Liver Transplantation

Liver Transplantation at Baylor:
Disease-Specific Results and Long-Term Outcomes

Robert M. Goldstein

Table 6. Outcomes in patients with known hepatomas treated with neoadjuvant perioperative plus postoperative chemotherapy compared with those with incidental hepatomas treated only postoperatively

Groups	Patient Survival Three Years	Disease-Free Survival	Predominant TNM Stage	Total # Recurrences
Known (Gr. 1) n=33	54.5%	45.7±6.1 mos (58.3%*)	IVA	11
Incidental (Gr. 2) n=14	45.7%	34.3±3.1 mos (64.9%*)	III	4

* Chance of no recurrence at three years.

Go to top · Return to Chapter · Return to Table of Contents

Please be aware that medical advice, diagnoses and physician references cannot be obtained from this site.